Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared a post on X about a recent paper by him and colleagues published in HemaSphere:
“Finally published!
Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma.”
Authors: Maximilian Merz, Anca-Maria Albici, Bastian von Tresckow, Thomas Pabst, Nico Gagelmann et al.
More posts featuring Nico Gagelmann.